Trials / Completed
CompletedNCT02881255
Avoid Transvenous Leads in Appropriate Subjects
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 544 (actual)
- Sponsor
- Population Health Research Institute · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to compare standard, single chamber transvenous ICD to sub-cutaneous ICD in occurrence of perioperative and long term device related complications and failed appropriate clinical shocks and arrhythmic death.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Implantable Cardioverter Defibrillator | Patients will be randomized to receive either a subcutaneous or transvenous ICD. |
Timeline
- Start date
- 2017-02-22
- Primary completion
- 2022-01-31
- Completion
- 2022-02-10
- First posted
- 2016-08-26
- Last updated
- 2022-05-31
Locations
14 sites across 1 country: Canada
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT02881255. Inclusion in this directory is not an endorsement.